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The pathogenic chytrid fungus Batrachochytrium dendrobatidis (Bd) can cause
precipitous population declines in its amphibian hosts. Responses of individ-
uals to infection vary greatly with the capacity of their immune system to
respond to the pathogen. We used a combination of comparative and exper-
imental approaches to identify major histocompatibility complex class II
(MHC-II) alleles encoding molecules that foster the survival of Bd-infected
amphibians. We found that Bd-resistant amphibians across four continents
share common amino acids in three binding pockets of the MHC-II antigen-
binding groove. Moreover, strong signals of selection acting on these specific
sites were evident among all species co-existing with the pathogen. In the lab-
oratory, we experimentally inoculated Australian tree frogs with Bd to test
how each binding pocket conformation influences disease resistance. Only
the conformation of MHC-II pocket 9 of surviving subjects matched those of
Bd-resistant species. This MHC-II conformation thus may determine amphi-
bian resistance to Bd, although other MHC-II binding pockets also may
contribute to resistance. Rescuing amphibian biodiversity will depend on
our understanding of amphibian immune defence mechanisms against Bd.
The identification of adaptive genetic markers for Bd resistance represents
an important step forward towards that goal.1. Introduction
The emerging infectious skin disease chytridiomycosis, caused by the chytrid
fungus Batrachochytrium dendrobatidis (denoted Bd) [1,2], is a primary driver
of global amphibian population declines and species extinctions [3,4]. Bd colo-
nizes the keratinized epithelial cells of its host’s skin [2]. In susceptible
amphibians, acute infections can disrupt membrane potentials, leading to
paralysis and heart failure [5]. Bd has been detected in more than one-third
of all amphibian species surveyed around the world [3,4]. Disease progression,
and whether infection culminates in morbidity or mortality, depends on many
factors, especially the capacity of the host immune system to respond to the
infection [6]. Thus, even in the midst of epizootics, variation exists among indi-
viduals in their vulnerability to the disease. In amphibian communities, some
species thrive even as others around them perish.
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receptors at the cell surface that induce and regulate acquired
immune responses against pathogens in all jawed vertebrates
[7]. Resistance of amphibians to bacterial and viral diseases
that cause population die-offs has been demonstrated to be
conferred by particularMHCalleles [8,9]. A recent study ident-
ified possible MHC allele-specific disease resistance to
chytridiomycosis [10]. These findings suggest that features of
MHC molecules may improve their capacity to bind Bd anti-
gens and induce adaptive immune responses. If the results
have some generality, alleles that encode these molecules
should be strongly selected in infected populations.
Many variable amino acid residue positions associated
with disease susceptibility in vertebrates are situated in exon
2 of the MHC class II (MHC-II) B gene [11,12], which encodes
theb1 segment of the antigen-binding groove that presents epi-
topes to T cells [7]. The stability of the antigen–MHC complex
depends mainly on deep pockets within the binding groove
that interact directly with antigen residues [12]. Amino acid
changes in this segment result in important structural modifi-
cations of the binding groove that can change the affinity
of the MHC molecule for particular antigens [11,12]. The
MHC-II b1 domain of several amphibian species has been
sequenced [10,13–16] and residue positions important for anti-
gen binding may be under positive selection [10,15]. Analyses
of Bd resistance among amphibians as a function of theirMHC-
II b1 domain offer a means to examine the evolution of resist-
ance to Bd and to identify specific MHC conformations that
confer Bd resistance.
Here, we use a combination of comparative and exper-
imental approaches to demonstrate selection for MHC
conformations that foster the survival of Bd-infected amphi-
bians across four continents. We show that resistant
amphibians share amino acids within the MHC-II binding
groove. We assess how specific sites in this region affect the
conformation and binding affinities of MHC molecules that
are important in conferring Bd resistance.We then test our pre-
dictions by conducting laboratory challenge experiments on a
threatened Australian tree frog species, comparing survivor-
ship of MHC genotypes in populations that have evolved
with Bd to those that remain naive to the pathogen.2. Material and methods
(a) Sample collection
In South Korea, we obtained 30 toe-clip samples from wild-caught
Asiatic toads (Bufo gargarizans) in Geumsan (3688.2490 N,
127822.8760 E) and Jeonju (35847.2410 N, 12788.3480 E), and 10
samples from wild-caught oriental fire-bellied toads (Bombina
orientalis) in Chuncheon (37858.6640 N, 127836.1460 E) andChiaksan
(37823.6760 N, 128803.2210 E) (electronic supplementary material,
table S1). These two species historically have been infected by ende-
mic Bd strains in Korea and show no evidence of morbidity nor
mortality attributable to chytridiomycosis despite extensive field-
work having been undertaken [17]. In Australia, we obtained
toe-clip samples from 30 wild alpine tree frogs (Litoria verreauxii
alpina) in each of three similar but geographically separate popu-
lations in Kosciuszko National Park, New South Wales. Two of
the three populations were long-exposed to the pathogen (site A,
Kiandra, 35852.3350 S, 148829.9940 E; site B, Ogilvies Creek,
3682.1750 S, 148819.3270 E) and a third never had been exposed to
Bd (site C, Grey Mare Range, 36819.0100 S, 148815.5670 E).(b) MHC-II b1 genotyping and structure comparison
DNA was extracted from toe clips using a salting-out extraction
method with ammonium acetate [18]. We used existing primers
forB. gargarizans andnewly designedprimers (see detailedmethods
in electronic supplementarymaterial) for L. v. alpina and B. orientalis
to genotype samples at the b1 domain of one MHC-II locus. Full
details of primer sequences and PCR protocols are given in elec-
tronic supplementary material, table S2. MHC-II b1 amplicons
were purified and cloned using the RBC A&T cloning kit and
accompanying HIT-DH5 a competent cells (RC001 and RH617,
RBC Bioscience, Taipei, Taiwan) following the manufacturer’s pro-
tocol. Between 8 and 20 clones were amplified by PCR (electronic
supplementary material, table S2) and sequenced using M13 pri-
mers. Allelic identity was confirmed when the corresponding
DNA sequence was found in at least two clones. Only one or two
alleles were recovered from any of our samples, confirming that
our primers targeted one single MHC-II locus in all species.
Sequences obtained were aligned with MHC-II b1 sequences
of 17 amphibian species from around the world that vary in
susceptibility to Bd [19–25] (length of sequences: 37–81 amino
acids; complete list in electronic supplementary material,
figure S1; GenBank accession numbers KJ679288–KJ679331)
using CLUSTAL W [26]. Sequences then were translated into amino
acids using BIOEDIT [27]. We examined the amino acid composition
at 15 codon positions known to affect the properties of the P4
(seven sites), P6 (four sites) and P9 (four sites) pockets of the
MHC-II peptide-binding groove in humans [11,12]. Codon b9 of
pocket P9 was not evaluated because it was missing from more
than half of our dataset. The most frequent amino acid across
MHC-II b1 sequences of Bd-resistant amphibians was recorded
for each of the 15 positions.
We hypothesized that these most frequent amino acid compo-
sitions represent pocket conformations associated with Bd
resistance. Allelic frequencieswithin populations could not be con-
sidered because such data are not available for most amphibian
species. Nevertheless, if Bd induced strong selection for particular
MHC-II conformations, wewould expect to find a trend. Failure to
find a relationship, however, would not allow us to draw any con-
clusion. For each MHC-II binding pocket, the proportion of b1
sequences containing all the amino acids most frequent in resistant
amphibians was compared with that characteristic of susceptible
species. Statistical significance was assessed by two-sample tests
of equality of proportions, correcting for multiple tests with the
Benjamini and Hochberg’s procedure [28], using the statistical
platform R v. 3.0.2 [29].(c) Microsatellite genotyping and data analysis
A panel of nine microsatellite markers, including two markers
isolated from the Litoria ewingii complex [30] and seven from a
L. v. alpina partial genomic DNA library (see the electronic
supplementary material), was organized into two fluorescently
labelled multiplexes, and multiplex PCR was performed with
Qiagenmultiplex PCRmaster mix following the method described
in electronic supplementarymaterial, table S3 [31]. Details ofmicro-
satellite primers, GenBank accession numbers and PCR protocols
are given in electronic supplementary material, table S3. Allele
sizes were assigned using an ABI3730 DNA analyser at NICEM
(Seoul National University, South Korea) and PEAK SCANNER v. 1.0
(Applied Biosystems, Carlsbad, CA, USA). Conformity to
Hardy–Weinberg equilibrium and linkage disequilibrium was
determinedwithGENEPOP v. 4.0 [32].Heterozygosity values and fre-
quency of null alleles were estimated with CERVUS [33].
Frequency of null alleles was high (F. 0.10) for four markers
(Livea-GT1, Livea-AG3, Le2 and Le4) in the three populations
genotyped. Therefore, we statistically adjusted allele frequencies
assuming a single new allele size by generating a new genotyp-
ing dataset corrected for null alleles in FREENA [34]. Subsequent
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nine-marker dataset corrected for null alleles.
(d) Experimental infection
Fifteen clutches of L. v. alpina were collected from the three popu-
lations described above. Frogs were reared in Bd-free quarantine
conditions to adulthood. Frogs were confirmed to be Bd-negative
byqPCR[35]prior to thecommencementof theexposureexperiment.
Two hundred adults were randomly chosen from each clutch
and population to be assigned to treatments that were inoculated
with 750 000 infective Bd zoospores (strain AbercrombieNP-
L.booroolongensis-09-LB-P7). The experimental design, involving
the utilization of frogs from each population and clutch together
with details of the blind randomized block design used for
allocation of treatment groups, is outlined in electronic supplemen-
tary material, table S4. As a control, another 56 frogs were
sham-infected with culture medium in dilute salt solution. Num-
bers of frogs available for treatments were subject to actual
clutch sizes and natural attrition during growth and development.
Frogs were maintained in a quarantine room at temperatures
between 18 and 208C under a 12 L : 12 D regimen. Subjects were
housed individually in small plastic tubs on an angled rack with
drainage holes, a loose pebble floor and a gauze-covered top.
They were fed twice weekly with vitamin-dusted (calcium and
herptivite alternately) crickets, and tubs were cleaned daily by
flushing with fresh filtered water.
Subjects were monitored daily for clinical signs of infection
(dullness, lethargy, peripheral erythema and increased skin shed-
ding). Bd infection intensity data were collected weekly by
swabbing all subjects, each with fresh gloves and a new sterile
dry swab (MW100; Medical Wire and Equipment, Corsham, UK).
Infection intensity was estimated as Bd zoospore equivalents
(ZSE) in each swab sample using a TaqMan real-time qPCR assay
[35] and standards with known Bd quantity. Individual swabs
were analysed in triplicate with an internal positive control. Once
the last surviving subjects effectively cleared themselves of Bd
infection (0–10 ZSE) over four successive weeks, the experiment
was terminated.
Frogs showing marked clinical signs of chytridiomycosis were
euthanized throughout the experiment using tricaine methanesul-
fonate (MS-222). Subjects to be sacrificed first were swabbed to
quantify Bd infection intensity by qPCR. Foot or toe-clip samples
for MHC analysis were collected post-mortem soon after sacrifi-
cing subjects and were placed into 90% ethanol. We genotyped
the MHC-II b1 domain in 100 L. v. alpina that we had infected
with Bd. This selection included the only six individuals that sur-
vived the experiment and 94 individuals randomly chosen and
encompassing all the clutches collected from the three populations
(8–10 individuals per clutch; electronic supplementary material,
table S4).
(e) Survival statistical analysis
WeusedCox proportional hazardmodels [36] to identify variables
that affected survival of L. v. alpina during the experiment.
Parameters included in the initial model were site of origin,
clutch, maximum Bd infection load, mass at the start of the exper-
iment, change in mass over the course of the experiment, MHC
heterozygosity, allelic divergence (measured as p-distance) and
pocket residue composition (table 1). We also examined two-way
interaction terms between maximum infection load and the other
variables, and between masses and the other variables sequen-
tially. We used likelihood ratio tests to calculate the predictive
power of each variable. Independent variables that did not show
a significant association with length of survival were excluded
from the model. The significance of each variable’s effect on
hazard risk was evaluated with Wald z statistics. Analyses were
conducted with the ‘survival’ package in R v. 3.0.2.
+Buga
+Boor
+Bobo
+Bova
+Bopa
+Bubu
+Buca
+Raya-Q
–Raya-others
+Raca
–sRana
–Alob
+Xela
+Anda
+Anme/Amti
+Livea-R
–Livea-S
P4 pocket residue
P4/P7 pocket residue
P6 pocket residue
P6/P7 pocket residue
P9 pocket residue
+Bd-resistant/–Bd-susceptible
Figure 1. Alignment of the b1 domain of the MHC class II in amphibians illustrating peptide-binding residues. Each sequence in the alignment represents a consensus
sequence grouping alleles isolated in a species, or in a subgroup within species. Susceptibility of each was determined by experimental infections or field observation of
Bd-associated population declines. Positions encoding amino acids similar to Bd-resistant Bufo gargarizans are represented by a dot. Variable positions in consensus
sequences are represented by the most frequent amino acid in the group (lower case letters). Dashes indicate missing data. Peptide-binding residues are highlighted
in colours, as denoted, to indicate their association with pockets of the MHC peptide-binding groove. Bd-resistant Litoria verreauxii alpina (Livea-R), Bd-susceptible
L. v. alpina (Livea-S), Bufo gargarizans (Buga), Bombina orientalis (Boor), Bombina bombina (Bobo), Bombina variegata (Bova), Bombina pachypus (Bopa), Bufo bufo
(Bubu), Bufo [Epidalea] calamita (Buca), Rana [Lithobates] yavapaiensis (Raya), Rana [Lithobates] catesbeiana (Raca), susceptible Rana spp. (sRana) including Rana [Litho-
bates] clamitans, R. pipiens, R. [Lithobates] sylvatica, R. [Lithobates] warszewitschii and Rana temporaria, Alytes obstetricans (Alob), Xenopus laevis (Xela), Andrias
davidianus (Anda), Ambystoma mexicanum and A. tigrinum (Anme/Amti). Raya-Q, allele from Rana [Lithobates] yavapaiensis associated with Bd resistance. The complete
alignment with all MHC-II b1 included in the study is available in the electronic supplementary material.
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Genetic variation among populations (FST) at MHC and micro-
satellite markers was calculated and compared with simulated
expected FST values in wild L. v. alpina populations using Fdist
[37] implemented in LOSITAN [38]. Markers with FST values
significantly higher than the simulated distribution (posterior prob-
ability more than 0.95) were considered to be under positive
selection. Analyses were done on the full dataset including
the three populations, and on pairs of populations, to identify popu-
lation-specific differences in selection pressure. Balancing or
directional selection affectingMHC-II inwildL. v. alpinapopulations
was also assessed using two tests based on deviation of allele fre-
quencies from neutral expectation (Watterson’s homozygosity test
[39] and Slatkin’s exact test [40]) conducted in ARLEQUIN v. 3.5 [41].
Selection pressures on the MHC-II b1 domain were assessed
byestimating the ratio of non-synonymous to synonymous nucleo-
tide substitutions using multiple methods available on the
Datamonkey website [42]. First, we confirmed the absence of
recombination in our sequences using single breakpoint recombi-
nation (SBR) and genetic algorithms for recombination detection
(GARD) [43]. To estimate the ratio of non-synonymous to
synonymous nucleotide substitutions, we used the partitioning
approach for robust inference of selection (PARRIS) [44] (v ¼
dN/dS; positive selection: v. 1). Analyses were conducted
across MHC-II b1 sequence alignments to identify the selection
model best fitting our data. Positively selected sites were detected
using single-likelihood ancestor counting (SLAC), fixed effects
likelihood (FEL), random-effects likelihood (REL) analysis [45]
and mixed-effects model of evolution (MEME) [46]. We also
testedwhether specific biochemical propertieswere driving substi-
tutions at the peptide-binding sites using the property-informed
model of evolution (PRIME) method [42], which includes the
Holm–Bonferroni procedure to control for familywise false
positives within sites.3. Results
(a) Comparison of MHC-II b1 in worldwide
amphibians
The MHC-II b1 alleles of amphibian species least affected by
Bd infection [21–25] consistently presented the same amino
acids, or amino acids with similar chemical properties, at all
15 pocket residues (figure 1 and table 1; electronic supplemen-
tary material, figure S1). By contrast, these pocket-specific
amino acid compositions were less frequent in species sus-
ceptible to Bd [19,20] (P4: x21 ¼ 5:51, p ¼ 0.009; P6:
x21‘ ¼ 19:13, p, 0.001; P9: x21 ¼ 2:99, p ¼ 0.04; table 1).
In wild populations of both B. gargarizans and B. orientalis,
MHC-II alleles with the specific pocket 9 composition were
more frequent than alleles with other P9 compositions (frequen-
cies: B. gargarizans in Geumsan, 58.3%, x21 ¼ 3:33, p¼ 0.03, in
Jeonju, 81.6%, x21 ¼ 48:13; p, 0.0001; B. orientalis in Chuncheon,
70.0%, x21 ¼ 4:49, p¼ 0.02, in Chiak, 85.0%, x21 ¼ 16:90, p,
0.0001; electronic supplementary material, table S1). By contrast,
MHC-II alleles with the identified pocket 4 and pocket 6 compo-
sitions were equally or less frequent than other alleles for both
species (frequencies: B. gargarizans, P4: 41.7%, p¼ 0.50, P6:
18.3%, p¼ 0.50; B. orientalis, P4 absent in all populations, P6:
37.5%, p¼ 0.48; electronic supplementary material, table S1).(b) Selection pressure and structural properties in
MHC-II b1
We detected site-specific positive selection acting on MHC-II
b1, including 14 of the 15 positions affecting the three
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tronic supplementary material, table S5). We identified codon
positions 37b and 56b of pocket P9 in Bombina and Bufo sp.,
and 26b of pocket 4 in Bombina sp., to be under purifying selec-
tion (electronic supplementary material, table S5). Variation at
positions 13b and 57b was associated with a change in the
chemical composition (property a1 in Conant–Stadler set of
amino acid properties [47]) at these sites (13b: weight property
a1 ¼ 22.312, p ¼ 0.01; 57b: a1 ¼ 23.496, p ¼ 0.05).
Electrically charged (e.g. negative Asp/Glu at 28b or 66b;
positive Arg/Lys at 71b) or hydrophobic (e.g. Tyr/Phe at 26b,
30b or 37b) amino acids were found for 12 of the 15 codon pos-
itions for amphibians with low susceptibility to Bd (table 1).
Amino acidswith these properties canmodulate anchor residue
specificity by changing the charge characteristics of the pockets
[12]. Other common amino acids, Valb11 and Serb13, increase
the space available within the pockets for large anchor residues
owing to their very small side chain [12]. Codon b56 encodes
proline, the only such amino acid within the peptide-binding
region of this MHC-II b locus (table 1; electronic supple-
mentary material, figure S1). Proline is an amino acid with
a unique conformational rigidity strongly affecting protein
secondary structure such as alpha helices [48].(c) Experimental infection of Litoria verreauxii alpina
After inoculating frogs with Bd, subjects from long-exposed
site A survived significantly longer than those from the other
long-exposed site B and naive site C (Kaplan–Meier p ¼
0.001; figure 2; electronic supplementary material, table S6).
Many subjects were heavily infected and died within five
weeks (figure 2). Infection loads of some individuals from
sites A and C stabilized after five weeks but increased after-
wards, leading to morbidity and mortality after eight weeks.
Six of 200 frogs (five from site A, one from site C) demonstrated
greatly reduced loads after three weeks and survived until the
end of the experiment (figure 2). All non-exposed, control frogs
survived until the end of the experiment.
We genotyped the b1 domain of one MHC-II locus in 84
individuals, including the six survivors, thatwe had inoculatedwith Bd. Twenty-two MHC-II b1 alleles were recovered, with
eight alleles identified among the surviving individuals
(Livea-1, 2, 3b, 5a, 5b, 11, 13 and 14; figure 3; electronic sup-
plementary material, table S6 and figure S1). These eight
alleles had identical residues at five codon positions associated
with the P9 pocket, corresponding to the composition ident-
ified in resistant amphibians worldwide (table 1 and figure 1;
electronic supplementary material, S1). Subjects that died had
significantly lower frequencies of alleles with the specific P9
pocket composition than those that survived (x21 ¼ 7:18, p ¼
0.004; table 1 and figure 3). None of the eight alleles had the
P4 pocket composition identified in the worldwide MHC-II
b1 alignment, and only two alleles had the targeted P6
pocket composition (table 1). We identified another 15 alleles
in individuals that did not survive infection. Six of these alleles
presented the P9 pocket composition identified in Bd-resistant
amphibians (figures 1 and 3; electronic supplementary
material, S1).
We used Cox proportional hazard models to determine
whether P6 and P9 pocket residue composition, MHC hetero-
zygosity and other variables affected the survivorship of
subjects during the experiment. The model that best fitted
the data included P6 and P9 pocket residue compositions, the
clutch and site of origin, and the interaction between P9 com-
position and the maximum Bd infection load (LRT¼ 61.88,
d.f. ¼ 13, p, 0.0001; detailed results of the model in electronic
supplementary material, table S7). Having the specific P9
pocket composition associated with Bd resistance in both
MHC-II alleles significantly increased survival (z ¼ 23.407,
p, 0.001, figure 3; electronic supplementary material, table
S7). Presence of two alleleswith the targetedP6 compositionhad
a significantly negative effect on survival (z ¼ 3.070, p ¼ 0.002).
Having only one allele with the P6 or P9 compositions did not
significantly improve survival (z ¼ 0.864, p ¼ 0.39, and
z ¼ 20.225, p ¼ 0.82, respectively; electronic supplementary
material, table S7). We did not observe any significant effect
of MHC heterozygosity or allelic divergence on survival
(LRT for model with MHC heterozygosity ¼ 61.98, x21 ¼ 0:10,
p ¼ 0.75; LRT for model with allelic divergence ¼ 65.27,
x21 ¼ 3:40, p¼ 0.07).
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Figure 3. Association of the MHC class II b1 domain with survival to Bd in L. v. alpina. (a) Frequency of MHC class II b1 alleles (Livea) in subjects that survived
(red) and succumbed (blue) to experimental infection by Bd, indicating alleles encoding the P9 and P6 pocket compositions most frequent in Bd-resistant amphi-
bians; frequency of individuals with two (2/2), one (1/2) or no (0/2) MHC-II b1 alleles with the specific P9 residue composition. (b) Survival curves for individuals
during the course of the Bd infection experiment with respect to the presence of the specific P9 pocket residue composition in two (2/2), one (1/2) or none (0/2) of
their two MHC-II b1 domains.
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The best-fitting selection model allowed for site-specific posi-
tive selection (v ¼ 3.14, LRT ¼ 6.58, p ¼ 0.04). Along with
other peptide-binding residues, residues b37 and b57 of the
P9 pocket were identified as being under positive selection
using REL analysis (posterior probability more than 0.99
for both residues). Residue b57 also was identified as being
under positive selection using MEME (p ¼ 0.002; electronic
supplementary material, table S5).
If MHC alleles with the specific P9 pocket conformation
are advantageous to L. v. alpina against Bd infection, we
should also observe signs of directional selection pressure on
this locus in wild L. v. alpina exposed to this pathogen. We
sampled 30 individuals from each of the three sites used as
source populations for the infection experiment. We geno-
typed these individuals for the MHC-II b1 domain and nine
microsatellite markers. Contrary to our predictions, the fre-
quency of P9-specific alleles in exposed site A (37.5%) was
lower than that of other alleles (x21 ¼ 5:04, p ¼ 0.50), whereas
P9-specific alleles were more frequent in exposed site B
(93.8%, x21 ¼ 70:04, p, 0.0001) and in naive site C (97.5%,
x21 ¼ 84:38, p, 0.0001). Levels of MHC heterozygosity were
high in all populations (60–65%). Genetic variation among
populations (measured as FST) was significantly higher at the
MHC-II locus than at the microsatellite loci among the popu-
lations (FST ¼ 0.147, posterior probability more than 0.99;
electronic supplementary material, table S7), suggesting that
directional selection is affecting the MHC class II locus
across populations [49]. However, Watterson’s F-test and Slat-
kin’s exact p-test did not detect any significant deviation from
neutrality in MHC allele frequencies of the three populations
(Watterson: p ¼ 0.927 (site A), 0.337 (B), 0.336 (C); Slatkin:
p ¼ 0.912 (A), 0.162 (B), 0.556 (C)).4. Discussion
We have shown that chytridiomycosis appears to select for
specific properties of the MHC class II molecule P9-binding
pocket. This is apparent both in our experimental infection
study of L. v. alpina and our surveys of wild populations of
Bd-resistant Bufo and Bombina species in Korea. While our
comparative study also points to specific P4 and P6 pocketconformations that correlate with Bd resistance worldwide,
these conformations did not improve survival of infected
L. v. alpina, nor are they abundant in Korean Bufo and
Bombina populations. Possibly, the importance of the various
antigen-binding pockets in triggering an efficient immune
response varies with hosts, infecting Bd strains and
environmental factors.
The protective P9 pocket conformation includes an aromatic
b37, an acidic Aspb57, a Prob56 and a hydrophobic b60 resi-
due. We could not fully assess the importance of b9, another
P9 peptide-binding residue, because the position is missing
from sequences of many of the species that we examined. Resi-
due Prob56, although not directly binding to anchor residues of
epitopes, may be of especial importance for efficient Bd antigen
binding by influencing how the peptide-binding residue b57 is
positioned within the P9 pocket [48].
Our experimental study on L. v. alpina demonstrates
adaptive immune-system-mediated recovery during infection
solely in individuals bearing twoMHC alleles with the advan-
tageous P9 conformation. MHC alleles are co-dominantly
expressed [50], so two doses ofMHCmolecules binding prefer-
entially to Bd peptidesmay be required to offset the pathogen’s
mechanism of attack on the adaptive immune system [51].
Alternatively, MHC alleles with the protective P9 conforma-
tion may interact more efficiently with the specific repertoire
of T-cell receptors or T-cell subsets that respond to Bd antigens
[52]. Many individuals with the advantageous P9 pocket
conformation nonetheless died. The protective effect of MHC
class II b1 molecules may be modulated by other factors regu-
lating immune system function. The high virulence of the Bd
strain to the frogs, indicated by massive infection loads borne
by some subjects (figure 2; electronic supplementary material,
table S6), may have resulted in effective inhibition of adaptive
immunity [51].
Results from wild L. v. alpina populations show only weak
evidence of selection for specific alleles of the MHC class II
locus in infected populations. Inhibition of immune response
may prevent selection of advantageous MHC alleles in the
wild. However, the differential survival of subjects from the
two historically infected sites suggests that selection for
resistance to Bd varies among sites. Genetic variation and
environmental factors may influence how strongly resistance
alleles are selected in infected populations.
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MHC heterozygosity [10,49]. The variation at the P9 pocket
residues that we observed in amphibian populations long
exposed to Bd is consistent with this view, although we did
not observe any evidence of heterozygote advantage in our
infection experiment. Amphibian populations with high fre-
quencies of resistance alleles together with substantial MHC
heterozygosity should be those most likely to recover from
infection by Bd. Yet resistance alleles may have pleiotropic
deleterious effects, including decreased growth, development
or survival [8]. Heterozygosity may mitigate these effects in
some conditions. It also may afford enhanced resistance
against different Bd strains, as well as other fungal, bacterial
and viral pathogens [8,9]. However, heterozygotes are not
always more resistant than homozygotes to single infectious
pathogens [53] such as Bd.
Further work is needed to assess the prevalence of the three
pocket conformations in other Bd-resistant species. Also, our
work suggests that the frequency of these conformations
should increase in susceptible species as populations recover
from chytridiomycosis epizootics. These MHC markers may
make possible the identification of those amphibian popu-
lations most susceptible to Bd. Knowing which species are
most at risk should facilitate the prioritization of conservation
efforts and allow more accurate projections as to how Bd will
affect complex host assemblages [54]. For those species now
dependent on ex situmanagement for their very survival, selec-
tive breeding for Bd resistance may make possible successful
re-introductions even into those areas in which Bd is enzootic.
The molecular bases of resistance also may be critical to the
development of immunization strategies. But much remains
to be learned before these actions become practicable.
For most species included in our study, we have compared
MHC-II b1 sequences obtained from one specific locus. Yet the
MHC complex of many amphibians consists of at least two
class II loci [14,15]. The structure and role of those additional
loci in conferring disease resistance need to be further studied.
In addition, the capacity of Bd to produce factors inhibiting
amphibian adaptive immune response represents a major
issue for any mitigation strategy based on adaptive immunity
[51] that needs to be further elucidated.Recent studies demonstrate that innate and adaptive
immune defence systems can confer resistance against Bd
[6,55,56]. Our study demonstrates for the first time that
susceptibility to chytridiomycosis is associated with selection
for specific immunogenetic traits across a wide variety
of amphibians. Around the world, some amphibian species
appear to have evolved immunity to chytridiomycosis
through a common mechanism. Rescuing amphibian bio-
diversity will depend on our understanding of amphibian
innate and adaptive immune defence mechanisms against
Bd. The identification of adaptive markers for Bd resistance
is an important step forward towards that goal.
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